Cardlytics Inc (NASDAQ: CDLX) is 56.13% higher on its value in year-to-date trading and has touched a low of $4.94 and a high of $20.52 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDLX stock was last observed hovering at around $13.32 in the last trading session, with the day’s gains setting it 1.06%.
Currently trading at $14.38, the stock is 3.61% and 45.26% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing 7.96% at the moment leaves the stock 36.04% off its SMA200. CDLX registered 128.98% gain for a year compared to 6-month loss of 5.12%. The firm has a 50-day simple moving average (SMA 50) of $2.61 and a 200-day simple moving average (SMA200) of -$8.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 66.24% gain in the last 1 month and extending the period to 3 months gives it a 100.28%, and is 10.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.01% over the week and 11.95% over the month.
Cardlytics Inc (CDLX) has around 434 employees, a market worth around $634.30M and $309.20M in sales. Profit margin for the company is -43.56%. Distance from 52-week low is 191.09% and -29.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.78%).
Cardlytics Inc quarterly earnings per share for the current quarter are estimated at -$0.11 with sales reaching $71.69M over the same period.The EPS is expected to grow by 66.80% this year, but quarterly earnings will post 9.20% year-over-year. Quarterly sales are estimated to grow 11.40% in year-over-year returns.
177 institutions hold shares in Cardlytics Inc (CDLX), with institutional investors hold 71.35% of the company’s shares. The shares outstanding are 44.11M, and float is at 41.10M with Short Float at 14.48%. Institutions hold 68.71% of the Float.
The top institutional shareholder in the company is CAS Investment Partners, LLC with over 5.42 million shares valued at $34.23 million. The investor’s holdings represent 14.36% of the CDLX Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 2.86 million shares valued at $18.05 million to account for 7.57% of the shares outstanding. The other top investors are 683 Capital Management LLC which holds 2.05 million shares representing 5.43% and valued at over $12.96 million, while Vanguard Group Inc holds 4.72% of the shares totaling 1.78 million with a market value of $11.25 million.
Cardlytics Inc (CDLX) Insider Activity
The most recent transaction is an insider sale by Temsamani Karim Saad, the company’s Chief Executive Officer. SEC filings show that Temsamani Karim Saad sold 32,564 shares of the company’s common stock on Apr 02 ’24 at a price of $13.69 per share for a total of $0.45 million. Following the sale, the insider now owns 0.34 million shares.
Cardlytics Inc disclosed in a document filed with the SEC on Apr 02 ’24 that Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) sold a total of 12,460 shares of the company’s common stock. The trade occurred on Apr 02 ’24 and was made at $13.69 per share for $0.17 million. Following the transaction, the insider now directly holds 71355.0 shares of the CDLX stock.
Still, SEC filings show that on Apr 01 ’24, Temsamani Karim Saad (Chief Executive Officer) disposed off 154 shares at an average price of $14.41 for $2219.0. The insider now directly holds 344,580 shares of Cardlytics Inc (CDLX).
